Retatrutide is investigational globally as of April 2026 and should be handled only within appropriate research protocols
We adopted an active comparator new user design where analysis was of new starters of each drug
Across anti-obesity medications broadly, gastrointestinal disorders represent the most frequent adverse events (29.10%), followed by central/peripheral nervous system disorders (19.17%) and psychiatric manifestations (16.87%)
Months 6+: With consistent use, you reach more peak results, including improvements in body composition, skin health, hair quality, and overall vitality
These strategies help patients get the most from their investment and create healthier habits that last beyond medication
Treatment decisions may depend on: Age Health status Biological age markers Sleep quality Longevity goals Existing medical conditions Because peptide therapy is highly individualized, dosing and treatment schedules should always be determined by a qualified medical professional
